APA

Isakoff S. J., Puhalla S., Domchek S. M., Friedlander M., Kaufman B., Robson M., Telli M. L., Diéras V., Han H. S., Garber J. E., Johnson E. F., Maag D., Qin Q., Giranda V. L. & Shepherd S. P. (20170223). A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. : Future oncology (London, England).

Chicago

Isakoff Steven J, Puhalla Shannon, Domchek Susan M, Friedlander Michael, Kaufman Bella, Robson Mark, Telli Melinda L, Diéras Véronique, Han Hyo Sook, Garber Judy E, Johnson Eric F, Maag David, Qin Qin, Giranda Vincent L and Shepherd Stacie P. 20170223. A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. : Future oncology (London, England).

Harvard

Isakoff S. J., Puhalla S., Domchek S. M., Friedlander M., Kaufman B., Robson M., Telli M. L., Diéras V., Han H. S., Garber J. E., Johnson E. F., Maag D., Qin Q., Giranda V. L. and Shepherd S. P. (20170223). A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. : Future oncology (London, England).

MLA

Isakoff Steven J, Puhalla Shannon, Domchek Susan M, Friedlander Michael, Kaufman Bella, Robson Mark, Telli Melinda L, Diéras Véronique, Han Hyo Sook, Garber Judy E, Johnson Eric F, Maag David, Qin Qin, Giranda Vincent L and Shepherd Stacie P. A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. : Future oncology (London, England). 20170223.